8th Circ. Again Revives FCA Suit Over Bayer Cholesterol Drug
The Eighth Circuit on Friday again resurrected a False Claims Act suit that alleged Bayer AG misled the U.S. Department of Defense about the risks of its now-defunct cholesterol drug Baycol,...To view the full article, register now.
Already a subscriber? Click here to view full article